RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Combination of dipeptidylpeptidase IV inhibitor and low dose thiazolidinedione: preclinical efficacy and safety in db/db mice.

Combination of dipeptidylpeptidase IV inhibitor and low dose thiazolidinedione: preclinical efficacy and safety in db/db mice.

Add to Collection
2007 Jun 13 Others Fist_Author_Year_PM

Full Author : ['Roy, Subhasis', 'Khanna, Vivek', 'Mittra, Shivani', 'Dhar, Arti', 'Singh, Shuchita', 'Mahajan, Dipak C', 'Priyadarsiny, Priyanka', 'Davis, Joseph A', 'Sattigeri, Jitendra', 'Saini, Kulvinder S', 'Bansal, Vinay S']
Journal Title : Life sciences
Chapter : Section3
Journal Year : 2007
Cited by : Not Available

Thiazolidinediones (TZDs) are currently the most efficacious class of oral antidiabetics. However, they carry the burden of weight gain and haemodilution, which may lead to cardiovascular complications. The present study was designed to ascertain whether .....

Keywords : ["low dose thiazolidinedione preclinical efficacy", "dipeptidylpeptidase iv inhibitor", "dbdb mouse", "safety", "combination"]